This Quarterly Report on Form 10-Q contains statements that may constitute
"forward-looking statements" within the meaning of Section 27A of the Securities
Act of 1933, as amended (the "Securities Act"), and Section 21E of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), that involve
substantial risks and uncertainties. All statements contained in this Quarterly
Report other than statements of historical fact, including statements regarding
our future results of operations and financial position, our business strategy
and plans, and our objectives for future operations, are forward-looking
statements. The words "believes," "expects," "intends," "estimates," "projects,"
"anticipates," "will," "plan," "may," "should," or similar language are intended
to identify forward-looking statements.

It is routine for our internal projections and expectations to change throughout
the year, and any forward-looking statements based upon these projections or
expectations may change prior to the end of the next quarter or year. Readers of
this Quarterly Report are cautioned not to place undue reliance on any such
forward-looking statements. As a result of a number of known and unknown risks
and uncertainties, our actual results or performance may be materially different
from those expressed or implied by these forward-looking statements. Risks and
uncertainties are identified under "Risk Factors" in Item 1A herein and in our
other filings with the Securities and Exchange Commission (the "SEC"). Unless
otherwise required by law, we do not undertake, and specifically disclaim, any
obligation to update any forward-looking statement, whether as a result of new
information, future events, or otherwise after the date of such statement.

As used in this section, unless the context suggests otherwise, "we," "us,"
"our," "Company," "Fast Radius" refer to Fast Radius, Inc., a Delaware
corporation (f/k/a ECP Environmental Growth Opportunities Corp. ("ENNV")),
collectively with Fast Radius Operations, Inc., a Delaware corporation ("Legacy
Fast Radius") and its consolidated subsidiaries. You should read the following
discussion and analysis of our financial condition and results of operations
together with our unaudited condensed consolidated financial statements and
related notes included elsewhere in this Form 10-Q, and Legacy Fast Radius'
audited consolidated financial statements and related notes for the year ended
December 31, 2021 included in our Current Report on Form 8-K/A filed with the
SEC on March 30, 2022.

Overview


We are a leading cloud manufacturing and digital supply chain company. We are
headquartered in Chicago with offices in Atlanta, Louisville, and Singapore and
micro-factories in Chicago and at the UPS Worldport facility in Louisville,
Kentucky.

We have built and are scaling a Cloud Manufacturing Platform which includes both
physical infrastructure - Fast Radius micro-factories and third-party supplier
factories - and a proprietary software layer. Our Cloud Manufacturing Platform
supports engineers, product developers, and supply chain professionals across
the product design and manufacturing lifecycle.

We offer a wide and growing range of manufacturing technologies, including additive manufacturing (often referred to as 3D printing), CNC machining, injection molding, sheet metal, urethane casting, and other manufacturing methods. We offer these manufacturing capabilities through our own micro-factories as well as a network of curated third-party suppliers.



Recent Developments
Business combination
On February 4, 2022 ("the Closing Date"), the Company consummated a business
combination with Legacy Fast Radius, pursuant to which ENNV Merger Sub, Inc., a
wholly owned subsidiary of the Company ("Merger Sub"), merged with and into
Legacy Fast Radius, with Legacy Fast Radius surviving the Merger as a wholly
owned subsidiary of the Company (the "Business Combination"). After giving
effect to the Business Combination, the Company owns, directly or indirectly,
all of the issued and outstanding equity interests of Legacy Fast Radius and its
subsidiary and the equity holders of Legacy Fast Radius immediately prior to the
Business Combination own a portion of the Company's common stock, par value
$0.0001 per share ("Common Stock").

While the legal acquirer in the Business Combination was ENNV, for financial
accounting and reporting purposes under U.S. GAAP ("GAAP"), Legacy Fast Radius
was the accounting acquirer and the Business Combination was accounted for as a
"reverse recapitalization." A reverse recapitalization (i.e., a capital
transaction involving the issuance of stock by ENNV for Legacy Fast Radius'
stock) does not result in a new basis of accounting, and the condensed
consolidated financial statements of the combined entity represent the
continuation of the condensed consolidated financial statements of Legacy Fast
Radius in many respects. Accordingly, the consolidated assets, liabilities and
results of operations of Legacy Fast Radius became the historical condensed
consolidated financial statements of the combined company, and ENNV's assets,
liabilities and results of operations were consolidated with those of Legacy
Fast Radius beginning on the acquisition date. Operations prior to the Business
Combination are presented as those of Legacy Fast Radius. The net assets of ENNV
were recognized at historical cost, with no goodwill or other intangible assets
recorded.

Concurrently with the execution of the Merger Agreement, ENNV entered into subscription agreements (collectively, the "Subscription Agreements"), with certain third-party investors, including, among others, UPS, Palantir and the Sponsor (the "PIPE Investors"),


                                       24
--------------------------------------------------------------------------------

pursuant to which the PIPE Investors agreed to subscribe for and purchase, and
ENNV agreed to issue and sell, to the PIPE Investors an aggregate of 7,500,000
shares of Common Stock (the "PIPE Shares") for a purchase price of $10.00 per
share, or an aggregate purchase price of $75.0 million, in a private placement
(the "PIPE Investment"). Under the Subscription Agreements, ENNV granted certain
registration rights to the PIPE Investors with respect to the PIPE Shares. The
PIPE Shares were issued concurrently with the closing of the Business
Combination on the Closing Date.

Upon consummation of the Business Combination, the closing of the PIPE
Investment and payment of certain other amounts that were contingent on the
closing of the Business Combination, the most significant change in our reported
financial position was an increase in cash and cash equivalents of approximately
$73 million, primarily due to $75.0 million in gross proceeds from the PIPE
Investment and $29.6 million in proceeds from the Trust Account, partially
offset by cash payments that were disbursed at the Closing which included $8.3
million of transaction expenses, $2.5 million in debt repayments, $8.2 million
in directors' and officers' ("D&O") insurance premiums, and $12.8 million
related to IT and other costs.

In connection with the Business Combination, over 31.5 million ENNV shares were
submitted for redemption. As a result, the condition to Fast Radius' obligation
to consummate the Business Combination that the amount of cash available in
ENNV's trust account immediately prior to the effective time of the Business
Combination, after deducting the amount required to satisfy payments to ENNV
stockholders in connection with the redemptions, the payment of any deferred
underwriting commissions being held in ENNV's trust account and the payment of
certain transaction expenses, plus the gross proceeds from the PIPE Investment
to be consummated in connection with the closing of the Business Combination, is
equal to or greater than $175 million (such condition, the "Minimum Cash
Condition") was not satisfied. Therefore, in connection with the closing of the
Business Combination, we waived the Minimum Cash Condition.

The reduction in available cash upon closing of the Business Combination due to
those share redemptions reduced our ability to invest in our growth strategy. As
our resources are insufficient to satisfy our cash requirements and future
growth objectives, we need to seek additional equity or debt financing. If the
needed financing is not available, or if the terms of financing are less
desirable than we expect, we will be forced to make additional changes to our
long-term growth strategy in the discretion of our management and the Board.
These changes may include, but are not limited to, decreasing our level of
investment in new product launches and related marketing initiatives and scaling
back our existing operations, which could have an adverse impact on our business
and financial prospects.

In addition, as a consequence of the Business Combination, we became the
successor to an SEC-registered and Nasdaq-listed company, which requires us to
hire additional personnel and implement procedures and processes to address
public company regulatory requirements and customary practices. We have incurred
and will continue to incur additional annual expenses as a public company for,
among other things, D&O liability insurance, director fees and additional
internal and external accounting, legal and administrative resources, including
increased audit and legal fees. Our future results of operations and financial
position will not be comparable to historical results as a result of the
Business Combination.

Restructuring


In June 2022, our Board of Directors approved a cost optimization initiative
that includes a workforce reduction of approximately 20% (including the
elimination of open roles). The purpose of the workforce reduction is to
streamline our operational structure, reducing our operating expenses and
managing our cash flows. We have commenced workforce reductions and expect to
complete these actions by the end of the third quarter of 2022. We are also
conducting a facility rationalization assessment and assessing other operational
savings measures. As a result of these actions, we anticipate that we will
realize annual run-rate cost savings of over $10 million. To generate these cost
savings, we will incur some non-recurring expenses in 2022, specifically
expenses associated with actions we've implemented in order to retain and
motivate key employees. These expenses will offset some of the cost savings in
the second half of 2022.

In the second quarter of 2022, we incurred costs of $598 thousand related to
these actions, of which approximately $153 thousand were related to non-cash
asset impairments and the remainder were cash severance costs. We continue to
pursue cost savings initiatives and, to the extent further cost savings
opportunities are identified, we may incur additional restructuring and related
charges in future periods.

COVID-19 pandemic
In March 2020, the World Health Organization declared the outbreak of the new
strain of the coronavirus ("COVID-19") to be a pandemic. The COVID-19 pandemic
is having widespread, rapidly evolving, and unpredictable impacts on global
society, economies, financial markets, and business practices. Federal and state
governments have implemented measures in an effort to contain the virus,
including social distancing, travel restrictions, border closures, limitations
on public gatherings, work from home, supply chain logistical changes, and
closure of non-essential businesses. To protect the health and well-being of its
employees, suppliers, and customers, the Company previously made substantial
modifications to employee travel policies, implemented office closures as
employees were advised to work from home, and cancelled or shifted its
conferences and other events to virtual-only. The COVID-19 pandemic has impacted
and may continue to impact the Company's business operations, including its
employees, customers, partners, and

                                       25
--------------------------------------------------------------------------------

communities, and there is substantial uncertainty in the nature and degree of
the pandemic's continued effects over time. In particular, the COVID-19 virus
continues to surge in various parts of the world, including China, and such
surges have impacts on the Company's suppliers and may cause supply chain
issues, parts shortages and delayed shipping times. COVID-19 and other similar
outbreaks, epidemics or pandemics could have a material adverse effect on the
Company's business, financial condition, results of operations, cash flows and
prospects as a result of any of the risks described above and other risks that
the Company is not able to predict.

If the COVID-19 pandemic continues for a prolonged duration, we or our customers
may be unable to perform fully on our contracts, which will likely result in
increases in costs and reductions in revenue. These cost increases may not be
fully recoverable or adequately covered by insurance. The long-term effects of
COVID-19 to the global economy and to us are difficult to assess or predict and
may include a further decline in the market prices of our products, risks to
employee health and safety, risks for the deployment of our products and
services and reduced sales in geographic locations impacted. Any prolonged
restrictive measures put in place in order to control COVID-19 or other adverse
public health developments in any of our targeted markets may have a material
and adverse effect on our business operations and results of operation.

Nasdaq Continued Listing Compliance
On June 9, 2022, we received written notice (the "Notice") from Nasdaq that,
based on the closing bid price of our Common Stock for the last 30 consecutive
trading days, we no longer comply with the minimum bid price requirement for
continued listing on The Nasdaq Global Market. Nasdaq Listing Rule 5450(a)(1)
requires listed securities to maintain a minimum bid price of $1.00 per share
(the "Minimum Bid Price Requirement"), and Nasdaq Listing Rule 5810(c)(3)(A)
provides that a failure to meet the Minimum Bid Price Requirement exists if the
deficiency continues for a period of 30 consecutive trading days. The Notice has
no immediate effect on the listing of the Common Stock on The Nasdaq Global
Market. Pursuant to the Nasdaq Listing Rules, we have been provided an initial
compliance period of 180 calendar days to regain compliance with the Minimum Bid
Price Requirement. To regain compliance, the closing bid price of the Common
Stock must be at least $1.00 per share for a minimum of 10 consecutive trading
days prior to December 6, 2022, and we must otherwise satisfy The Nasdaq Global
Market's requirements for listing. There are no assurances that we will be able
to regain compliance with The Nasdaq Global Market's continued listing
requirements.

Results of Operations
Three Months Ended June 30, 2022 Compared with the Three Months Ended June 30,
2021
The following table sets forth a summary of our consolidated results of
operations, as well as the dollar and percentage change for the period:

                                                     For the Three Months Ended June 30,
(in thousands)                               2022          2021         Change ($)      Change (%)
Revenues                                  $    7,275     $   4,867     $      2,408              49 %
Cost of revenues (1)                           7,015         4,062            2,953              73 %
Gross Profit                                     260           805             (545 )           -68 %
Operating expenses
Sales and marketing (1)                        5,877         5,283              594              11 %
General and administrative (1)                14,717         8,783            5,934              68 %
Research and development (1)                   1,897         1,541              356              23 %
Total operating expenses                      22,491        15,607            6,884              44 %
Loss from Operations                         (22,231 )     (14,802 )         (7,429 )            50 %
Change in fair value of warrants               1,326           201            1,125             560 %
Change in fair value of derivatives                -             6               (6 )           n/m
Interest income and other income
(expense), net                                    31            (6 )             37            -617 %
Interest expense, including
amortization of debt issuance costs           (1,313 )        (504 )           (809 )           161 %
Loss before income taxes                     (22,187 )     (15,105 )         (7,082 )            47 %
Provision for income taxes                         -             -                -             n/m
Net Loss                                  $  (22,187 )   $ (15,105 )   $     (7,082 )            47 %
(1) Includes stock-based compensation,
as follows:

Cost of Revenues                          $       27     $       3     $         24             800 %
General and Administrative                     1,834           151            1,683            1115 %
Selling and Marketing                            196            37              159             430 %
Research & Development                           505            16              489            3056 %
Total                                     $    2,562     $     207     $      2,355            1138 %




                                       26

--------------------------------------------------------------------------------

Revenues


Revenues increased 49% from $4.9 million to $7.3 million for the three months
ended June 30, 2022 compared to the prior-year period. The increase in 2022 was
attributable to sales from new customers and an increase in revenue from
existing customers.

Cost of Revenues
Cost of revenues increased 73% from $4.1 million to $7.0 million for the three
months ended June 30, 2022 compared to the prior-year period. The increase in
cost of revenues was primarily attributable to the increase in revenues.
Additionally, cost of revenues was impacted by an investment we made in a new
CNC manufacturing facility in 2021, which is currently running at low
utilization.

Operating Expenses
Sales and Marketing
Sales and marketing expenses increased 11% from $5.3 million to $5.9 million for
the three months ended June 30, 2022 compared to the prior-year period. The
increase in sales and marketing expenses in 2022 was attributable to increases
in spend related to organizational headcount growth within the function.

General and Administrative
General and administrative expenses increased 68% from $8.8 million to $14.7
million for the three months ended June 30, 2022 compared to the prior-year
period. The increase in general and administrative expense in 2022 was
attributable to an expense of $2.1 million we recorded for our software
subscription agreement with Palantir as well as higher stock compensation
expense of $1.7 million. We also recorded an expense of $452 thousand associated
with the commitment fee shares issued to Lincoln Park as part of the Purchase
Agreement. Additionally, we incurred incremental legal, consulting and
accounting costs to support our growth, including costs related to the Business
Combination, and new costs associated with being a publicly-traded company.

Research and Development
Research and development expenses increased 23% from $1.5 million to $1.9
million for the three months ended June 30, 2022 compared to the prior-year
period. The $1.9 million of research and development expenses for the three
months ended June 30, 2022 included $3.2 million of gross research and
development expenses, primarily related to our Cloud Manufacturing Platform,
that was offset by $1.3 million of internal-use software costs that were
capitalized. No software development costs were capitalized in the three months
ended June 30, 2021. The increase in gross spend in 2022 is attributable to our
continued focus on developing the Cloud Manufacturing Platform.

Change in fair value of warrants
The income recorded in 2022 was attributable to mark to market adjustments on
warrant liabilities and was attributable to a decrease in our enterprise
valuation.

Interest income and other income
The increase in interest income was primarily attributable to an increase in our
average money market account balance in 2022 as compared to 2021 due to the
proceeds received from the Business Combination.

Interest expense, including amortization of debt issuance costs The increase in interest expense was primarily attributable to higher outstanding debt levels in 2022 compared to 2021. Refer to Note 5 for additional information related to indebtedness.


                                       27
--------------------------------------------------------------------------------

Six Months Ended June 30, 2022 Compared with the Six Months Ended June 30, 2021 The following table sets forth a summary of our consolidated results of operations, as well as the dollar and percentage change for the period:



                                                     For the Six Months Ended June 30,
(in thousands)                              2022          2021         Change ($)      Change (%)
Revenues                                  $  13,537     $   8,663     $      4,874              56 %
Cost of revenues (1)                         12,644         7,028            5,616              80 %
Gross Profit                                    893         1,635             (742 )           -45 %
Operating expenses
Sales and marketing (1)                      12,213         8,752            3,461              40 %
General and administrative (1)               52,942        16,495           36,447             221 %
Research and development (1)                  5,229         2,687            2,542              95 %
Total operating expenses                     70,384        27,934           42,450             152 %
Loss from Operations                        (69,491 )     (26,299 )        (43,192 )           164 %
Change in fair value of warrants              6,621        (1,052 )          7,673            -729 %
Change in fair value of derivatives              30             6               24             400 %
Interest income and other income
(expense), net                                   30             3               27             900 %
Interest expense, including
amortization of debt issuance costs          (3,977 )        (549 )         (3,428 )           624 %
Loss before income taxes                    (66,787 )     (27,891 )        (38,896 )           139 %
Provision for income taxes                        -             -                -             n/m
Net Loss                                  $ (66,787 )   $ (27,891 )   $    (38,896 )           139 %
(1) Includes stock-based compensation,
as follows:


Cost of Revenues                          $     142     $       7     $        135            1929 %
General and Administrative                   19,379           370           19,009            5138 %
Selling and Marketing                         1,379            37            1,342            3627 %
Research & Development                        2,030            47            1,983            4219 %
Total                                     $  22,930     $     461     $     22,469            4874 %



Revenues
Revenues increased 56% from $8.7 million to $13.5 million for the six months
ended June 30, 2022 compared to the prior-year period. The increase in 2022 was
attributable to sales from new customers and an increase in revenue from
existing customers.

Cost of Revenues
Cost of revenues increased 80% from $7.0 million to $12.6 million for the six
months ended June 30, 2022 compared to the prior-year period. The increase in
cost of revenues was primarily attributable to the increase in revenues.
Additionally, cost of revenues was impacted by an investment we made in a new
CNC manufacturing facility in 2021, which is currently running at low
utilization.

Operating Expenses
Sales and Marketing
Sales and marketing expenses increased 40% from $8.8 million to $12.2 million
for the six months ended June 30, 2022 compared to the prior-year period. The
increase in sales and marketing expenses in 2022 was attributable to increases
in spend related to organizational headcount growth within the function.
Additionally, we recorded incremental stock compensation expense in the first
quarter of 2022 as our outstanding restricted stock units ("RSUs") included a
performance condition that became probable upon the closing of the Business
Combination.

General and Administrative
General and administrative expenses increased 221% from $16.5 million to $52.9
million for the six months ended June 30, 2022 compared to the prior-year
period. The most significant increase in 2022 was attributable to incremental
stock compensation expense in the first quarter of 2022 as our outstanding RSUs
included a performance condition that became probable upon the closing of the
Business Combination and cash bonuses paid to certain employees that were
contingent on the closing of the Business Combination. Additionally, we recorded
expense of approximately $7.9 million in 2022 related to our software
subscription agreement with Palantir. We also recorded an expense of $452
thousand in 2022 associated with the commitment fee shares issued to Lincoln
Park as part of the Purchase Agreement. Finally, we incurred incremental legal,
consulting and accounting costs to support our growth, including costs related
to the Business Combination, and new costs associated with being a
publicly-traded company.

                                       28
--------------------------------------------------------------------------------


Research and Development
Research and development expenses increased 95% from $2.7 million to $5.2
million for the six months ended June 30, 2022 compared to the prior-year
period. The $5.2 million of research and development expenses for the six months
ended June 30, 2022 included $7.3 million of gross research and development
expenses, primarily related to our Cloud Manufacturing Platform, that was offset
by $2.1 million of internal-use software costs that were capitalized. No
software development costs were capitalized in the six months ended June 30,
2021. The increase in gross spend in 2022 is attributable to our continued focus
on developing the Cloud Manufacturing Platform. Additionally, we recorded
incremental stock compensation expense in the first quarter of 2022 as our
outstanding RSUs included a performance condition related to the closing of the
Business Combination.

Change in fair value of warrants
The income recorded in 2022 was attributable to mark to market adjustments on
warrant liabilities and was attributable to a decrease in our enterprise
valuation.

Change in fair value of Derivatives
The income recorded in 2022 was attributable to mark to market adjustments on
embedded derivatives associated with 2021 convertible debt issuances. All
outstanding derivative liabilities, along with the related convertible debt
instruments, were converted into Common Stock at the closing of the Business
Combination. Refer to Note 5 and Note 13 of the consolidated financial
statements included elsewhere in this Report for additional information on
derivative liabilities.

Interest income and other income
The increase in interest income was primarily attributable to an increase in our
average money market account balance in 2022 as compared to 2021 due to the
proceeds received from the Business Combination.

Interest expense, including amortization of debt issuance costs The increase in interest expense was primarily attributable to higher outstanding debt levels in 2022 compared to 2021. Refer to Note 5 for additional information related to indebtedness.



Non-GAAP Financial Measures
In addition to our results determined in accordance with GAAP, we believe the
below non-GAAP financial measures are useful in evaluating our operational
performance. We use this non-GAAP financial information to evaluate our ongoing
operations and for internal planning and forecasting purposes. We believe that
this non-GAAP financial information, when taken collectively, may be helpful to
investors in assessing our operating performance.

We define "EBITDA" as net loss plus interest expense, income tax expense, depreciation and amortization expense.



We define "Adjusted EBITDA" as EBITDA adjusted for stock-based compensation,
changes in the fair value of warrant liability, changes in the fair value of
derivative liabilities, and transaction and related costs.

To provide investors with additional information regarding our financial results, we are presenting EBITDA and Adjusted EBITDA, non-GAAP financial measures, in the table below along with a reconciliation to net loss, the most directly comparable measure calculated and presented in accordance with GAAP.

Adjusted EBITDA We consider Adjusted EBITDA to be an important measure because it helps illustrate underlying trends in our business and our historical operating performance on a more consistent basis.



Our definition of Adjusted EBITDA may differ from that used by other companies
and therefore comparability may be limited. In addition, other companies may not
present Adjusted EBITDA or similar metrics. Thus, our adjusted EBITDA should be
considered in addition to, not as a substitute for, or in isolation from,
measures prepared in accordance with GAAP, such as net loss.

In addition, Adjusted EBITDA has limitations as an analytical tool, including:


although depreciation and amortization are non-cash charges, the assets being
depreciated and amortized may have to be replaced in the future, and Adjusted
EBITDA does not reflect cash used for capital expenditures for such replacements
or for new capital expenditures;

Adjusted EBITDA does not include the dilution that results from stock-based compensation or any cash outflows included in stock-based compensation, including from our purchases of shares of outstanding common stock;


                                       29
--------------------------------------------------------------------------------

Adjusted EBITDA does not reflect tax payments that may represent a reduction in cash available to us; and other companies may calculate Adjusted EBITDA differently, which reduces its usefulness as a comparative measure.



We provide investors and other users of our financial information with a
reconciliation of Adjusted EBITDA to net loss. We encourage investors and others
to review our financial information in its entirety, not to rely on any single
financial measure and to view Adjusted EBITDA in conjunction with net loss.

Stock compensation expense is a non-cash expense relating to stock-based awards
issued to executive officers, employees, and outside directors, consisting of
options and restricted stock units. We exclude this expense because it is a
non-cash expense and we assess our internal operations excluding this expense,
and we believe it facilitates comparisons to the performance of other companies
in our industry.

Change in the fair value of warrant liability is a non-cash gain or loss
impacted by the fair value of the issued liability-classified warrants. We
believe the assessment of our operations excluding this activity is relevant to
our assessment of internal operations and to comparisons with the performance of
other companies in our industry.

Change in the fair value of derivative liabilities is a non-cash gain or loss
impacted by the fair value of the derivative liabilities. We believe the
assessment of our operations excluding this activity is relevant to our
assessment of internal operations and to comparisons with the performance of
other companies in our industry.

Common stock commitment fee is a non-cash expense related to the issuance of
Common Stock in exchange for the Purchase Agreement entered into with Lincoln
Park as described in Note 7 to the condensed consolidated financial statements.
We believe the assessment of our operations excluding this activity is relevant
to our assessment of internal operations and to comparisons with the performance
of other companies in our industry.

Restructuring costs are non-recurring expenses, primarily cash severance payments, associated with our cost optimization initiative that includes a workforce reduction of approximately 20% and other related expenses.



Transaction costs are non-recurring costs for advisory, consulting, accounting
and legal expenses in connection with the Business Combination as well as
certain bonuses to employees that were contingent on the closing of the Business
Combination.

The following table provides a reconciliation of net loss, the most closely comparable GAAP financial measure, to EBITDA and Adjusted EBITDA:



                                 For the Three Months Ended June 30,        For the Six Months Ended June 30,
(in thousands)                         2022                 2021               2022                   2021
Net loss                         $         (22,187 )     $   (15,105 )   $        (66,787 )     $        (27,891 )
Interest expense                             1,313               504                3,977                    549
Income tax expense (benefit),
net                                              -                 -                    -                      -
Depreciation and amortization                  714               302                1,368                    533
EBITDA                                     (20,160 )         (14,299 )            (61,442 )              (26,809 )
Stock compensation expense                   2,562               207               22,930                    461
Change in fair value of
warrant liability                           (1,326 )            (201 )             (6,621 )                1,052
Change in fair value of
derivative liability                             -                (6 )                (30 )                   (6 )
Common stock commitment fee                    452                 -                  452                      -
Restructuring costs                            598                 -                  598                      -
Transaction costs                              570               773                5,564                  3,549
Adjusted EBITDA                            (17,304 )         (13,526 )            (38,549 )              (21,753 )



Liquidity and Capital Resources
We measure liquidity in terms of our ability to fund the cash requirements of
our business operations, including working capital and capital expenditure
needs, contractual obligations, including debt and other liabilities, and other
commitments, with cash flows from operations and other sources of funding. Our
current liquidity needs include the working capital to support the purchase of
custom component parts from our third-party supplier partners on behalf of our
customers. In many cases, we pay our suppliers prior to being paid by our
customers, resulting in a need for working capital. We also consume cash through
other growth initiatives, including investing in new micro-factories, sales and
marketing expenses and development of our Cloud Manufacturing Platform.
Additionally, we will consume cash for additional expenses as a public company
for, among other things, D&O liability insurance, director fees and additional
internal and external accounting, legal and administrative resources, including
increased audit and legal fees. Our ability to

                                       30
--------------------------------------------------------------------------------

maintain, expand and grow our business will depend on many factors, including our working capital needs and the evolution of our operating cash flows.



We had $37.9 million in cash and cash equivalents as of June 30, 2022. Upon
consummation of the Business Combination, we received approximately $73 million
in cash, primarily due to $75.0 million in gross proceeds from the PIPE
Investment and $29.6 million in proceeds from the Trust Account, partially
offset by cash payments that were disbursed at the Closing which included $8.3
million of transaction expenses, $2.5 million in debt repayments, $8.2 million
in D&O insurance premiums, and $12.8 million related to IT and other costs.
Certain other transaction costs associated with and liabilities assumed as a
result of the Business Combination totaling approximately $11 million as of June
30, 2022 have been deferred until later in 2022 or 2023.

In connection with the Business Combination, over 31.5 million shares were
submitted for redemption for an aggregate redemption amount of approximately
$315 million. The proceeds we received in connection with the Business
Combination were significantly less than the originally expected proceeds of
$445 million (assuming no redemptions). As discussed below, the reduction in
available cash upon closing of the Business Combination due to share redemptions
has negatively impacted our growth initiatives, our revenue and net loss
projections prepared in connection with ENNV's evaluation of the Business
Combination, and our liquidity, including the likelihood that holders of
Warrants will exercise their Warrants and the Company will receive cash proceeds
from the Warrants.

Purchase Agreement with Lincoln Park



On May 11, 2022, the Company entered into the Purchase Agreement with Lincoln
Park, pursuant to which Lincoln Park has committed to purchase up to $30.0
million of Common Stock. Under the terms and subject to the conditions of the
Purchase Agreement, the Company has the right, but not the obligation, to sell
to Lincoln Park, and Lincoln Park is obligated to purchase up to $30.0 million
of Common Stock. Such sales of Common Stock by the Company, if any, will be
subject to certain limitations, and may occur from time to time, at the
Company's sole discretion, over the 24-month period commencing on the date that
is one business day following the satisfaction of certain customary conditions,
including effectiveness of a registration statement covering the resale of such
shares of Common Stock. Refer to Note 7 for additional information related to
the Purchase Agreement. Sales to Lincoln Park, or the possibility that these
sales may occur, and any related volatility or decrease in market price of our
Common Stock, might make it more difficult for us to sell equity securities in
the future at a time and at a price that we deem appropriate.

Future Liquidity Requirements



We expect our capital expenditures and working capital requirements to continue
to increase in the immediate future as we are still in the growth stage of our
business and expect to continue to make substantial investments in our business,
including in the expansion of our product portfolio and research and
development, sales and marketing teams, in addition to incurring additional
costs as a result of being a public company. Our short-term liquidity priorities
are to pay off existing indebtedness and liabilities, to fund ongoing working
capital needs, and to invest in the Company's growth strategy.

Based on our results of operations and liquidity as of June 30, 2022, as further
described below, we believe our cash and cash equivalents, including the cash we
obtained from the Business Combination and the PIPE Investment, as well as
potential proceeds available under the Purchase Agreement with Lincoln Park, are
not sufficient to meet our working capital and capital expenditure requirements
for a period of at least twelve months from the date of this Quarterly Report on
Form 10-Q. We expect to seek additional capital in 2022 to fund our operations
and future growth. While we are facing challenging market conditions, we are
actively pursuing alternatives to address our liquidity needs. We are engaged
with our financial advisors and Board on this and it remains a top priority.
However, there can be no assurance that we will be able to obtain additional
debt or equity financing within the necessary timeframe or on terms acceptable
to us, if at all. Failure to secure additional funding in a timely manner or at
all will impact our liquidity, including the ability to service our debt and
other liabilities, and may require us to modify, delay or abandon some of our
planned future expansion or development, or to otherwise enact additional
operating cost reductions available to management, and could have a material
adverse effect on our business, operating results, financial condition, and
could force us to limit our business activities. Our estimates of our results of
operations, working capital and capital expenditure requirements may be
different than our actual needs, and those estimates may need to be revised if,
for example, our actual revenue is lower, and our net operating losses are
higher, than we project and our cash and cash equivalents position is reduced
faster than anticipated.

Projected Revenue and Net Loss



Prior to the Business Combination, Legacy Fast Radius provided certain
prospective financial information to ENNV for fiscal years 2021, 2022, 2023,
2024 and 2025 in connection with ENNV's evaluation of the Business Combination.
The prospective financial information was prepared using a number of
assumptions, including assumptions about the level of redemptions, which were
assumed to be significantly lower, and net cash proceeds resulting from the
consummation of the Business Combination, which were assumed to be significantly
higher. The prospective financial information included projected revenues and
net loss for the year ended December 31,

                                       31
--------------------------------------------------------------------------------

2021, of $23 million and $41 million, respectively. Similarly, the prospective financial information included projected revenues and net loss for the year ended December 31, 2022, of $104 million and $64 million, respectively.



For the year ended December 31, 2021, we recognized $20.0 million in revenue,
which was lower than our projected revenue of $23 million primarily due to a
significant customer order initially included in our projections for which we
later determined that revenue could not be recognized as we were not able to
assert that collection from the customer was probable under the requirements of
ASC 606. For the year ended December 31, 2021, we had net losses of
approximately $67.9 million, which were greater than our projected net loss of
$41 million primarily due to certain items that could not be forecasted at the
time the projections were presented including mark to market adjustments on
outstanding warrant and derivative liabilities, transaction costs related to our
Business Combination and interest expense related to indebtedness that had not
yet been issued. Additionally, our operating expenses were higher than initially
projected as we hired additional personnel to support our growth. Our actual
revenue being lower than projected revenue and our net operating losses being
higher than projected net operating losses for the year ended December 31, 2021,
had a negative impact on our cash and cash equivalents position.

For the six months ended June 30, 2022, we recognized $13.5 million in revenue,
and had net losses of approximately $66.8 million. Extrapolating these results
for the remainder of fiscal year 2022, we expect that our revenue for fiscal
year 2022 will be less than our projected $104 million and our net loss for
fiscal year 2022 will be greater than our projected $64 million that we provided
to ENNV in connection with ENNV's evaluation of the Business Combination. The
anticipated lower revenue, and anticipated higher net operating loss, for fiscal
year 2022 is expected to have a negative impact on our cash and cash equivalents
position. Accordingly, in connection with announcing the Company's financial
results for the quarter ended June 30, 2022, we revised our outlook for the year
ended December 31, 2022.

The anticipated lower revenue for fiscal year 2022 is due to the combination of
receiving lower proceeds than anticipated from the Business Combination, the
delay in the closing of the Business Combination until February 4, 2022, and the
increased customer acquisition spend of our competitors. We expected to receive
higher proceeds from the Business Combination, which we planned to invest in
acquiring new customers, expanding our manufacturing capability, expanding our
Cloud Manufacturing Platform and making strategic acquisitions. As the proceeds
from the Business Combination were significantly lower than expected, and
received later than expected, we had to reduce, delay or cancel our investments
in these growth initiatives.

The impact of these reductions in our planned growth investments in the six
months ended June 30, 2022, coupled with the increased cost associated with
acquiring customers as a result of our competitors' increased customer
acquisition spend, had a direct impact to our revenue, which is reflected by our
results for the six months ended June 30, 2022. If we had obtained significantly
higher proceeds from the Business Combination sooner, we believe we would have
been able to further accelerate our growth investments in the six months ended
June 30, 2022, and throughout 2022, which we believe would have enabled us to
achieve higher revenue for fiscal year 2022.

The anticipated higher net operating loss for fiscal year 2022 is due to the
reduction in anticipated revenues as discussed above, partially offset by the
reduction in anticipated expenses that would have been incurred to generate
those revenues, and higher stock-based compensation expenses that were not
included in our projections due to uncertainty around the timing for
consummating the Business Combination and modifications to certain awards that
impacted their valuation. Additionally, we are incurring higher costs than
anticipated as a public company.

Indebtedness and Effect of Resales

As of June 30, 2022, we had $28.7 million in debt, net of discounts and issuance costs, outstanding.



On February 4, 2022, the 2021 SVB Loan was amended to extend the maturity date
from the Closing Date to April 3, 2023 and required payment of $2.0 million of
the $20.0 million outstanding principal balance upon consummation of the
Business Combination. This amendment also added the original $0.8 million fee
due at the SPAC closing to the amended loan's outstanding principal balance,
deferring its repayment until maturity. In exchange for the extension of the
loan, we will pay an additional fee of $2.1 million due at maturity. We will
make six interest-only payments beginning March 1, 2022 and will begin paying
$2.4 million in principal beginning September 1, 2022.

Additionally, on February 4, 2022, as part of the closing of the Business Combination, the related party convertible notes that had a carrying value of $12.5 million as of December 31, 2021 were converted into Common Stock.



15,516,639 ENNV liability-classified warrants were also assumed as part of the
Business Combination with a carrying and fair value of $1.2 million as of June
30, 2022. Finally, certain other transaction costs associated with, and
liabilities assumed as a result of, the Business Combination totaling
approximately $11 million as of June 30, 2022 have been deferred until later in
2022 or 2023.


                                       32

--------------------------------------------------------------------------------

The shares of Common Stock registered for potential resale pursuant to the
prospectus we filed with the SEC on July 22, 2022 (File No. 333-264427) by the
selling securityholders thereunder represented approximately 74.8% of shares
outstanding on a fully diluted basis as of June 1, 2022. Given the substantial
number of shares of Common Stock registered for potential resale by selling
securityholders pursuant to such prospectus, the sale of shares by the selling
securityholders thereunder, or the perception in the market that the selling
securityholders intend to sell shares, could increase the volatility of the
market price of our Common Stock or result in a significant decline in the
public trading price of our Common Stock. These sales, or the possibility that
these sales may occur, and any related volatility or decrease in market price of
our Common Stock, might make it more difficult for us to sell equity securities
in the future at a time and at a price that we deem appropriate.

Warrant Proceeds



We would receive the proceeds from any exercise of any Warrants that are
exercised for cash pursuant to their terms. Assuming the exercise in full of all
of the Warrants for cash, we would receive an aggregate of approximately $178.4
million, but would not receive any proceeds from the sale of the shares of
Common Stock issuable upon such exercise. To the extent any Warrants are issued
on a "cashless basis," the amount of cash we would receive from the exercise of
the Warrants will decrease. We would expect to use any such proceeds received
from Warrants that are exercised for cash in the future for general corporate
and working capital purposes, which would increase our liquidity. However, we
will only receive such proceeds if and when the Warrant holders exercise the
Warrants. The exercise of the Warrants, and any proceeds we may receive from
their exercise, are highly dependent on the price of our Common Stock and the
spread between the exercise price of the Warrant and the price of our Common
Stock at the time of exercise. There is no assurance that the holders of the
Warrants will elect to exercise for cash any or all of such Warrants, and we
believe that any such exercise currently is unlikely to occur as described
below. As of the date of this Quarterly Report on Form 10-Q, we have neither
included nor intend to include any potential cash proceeds from the exercise of
our Warrants in our short-term or long-term liquidity projections. We will
continue to evaluate the probability of warrant exercise over the life of our
Warrants and the merit of including potential cash proceeds from the exercise
thereof in our liquidity projections.

We do not expect to rely on the cash exercise of Warrants to fund our
operations. Instead, we intend to rely on our primary sources of cash discussed
above to continue to support our operations. The exercise price of the Warrants
is $11.50 per share and the closing price of our Common Stock was $0.58 as of
August 4, 2022. Accordingly, we believe that it is currently unlikely that
holders of the Warrants will exercise their Warrants. The likelihood that
Warrant holders will exercise the Warrants, and therefore the amount of cash
proceeds that we would receive, is dependent upon the trading price of our
Common Stock. If the trading price for our Common Stock remains less than $11.50
per share, we believe holders of the Warrants will be unlikely to exercise their
Warrants. There is no guarantee that the Warrants will be in the money following
the time they become exercisable and prior to their expiration, and as such, the
Warrants may expire worthless and we may not receive any proceeds from the
exercise of the Warrants. To the extent that any of the Warrants are exercised
on a "cashless basis," the amount of cash we would receive from the exercise of
the Warrants will decrease.

Other commitments
In May 2021, we entered into a master subscription agreement with Palantir for
access to Palantir's proprietary software for a six-year period for a total of
$45.0 million. The non-cancellable future minimum payments due on this firm
purchase agreement are $10.1 million after taking into account the $9.4 million
payment made to Palantir at Close. Refer to Note 6 of the consolidated financial
statements included elsewhere in this Report for additional information on our
agreement with Palantir.

Cash Flows
The following table sets forth a summary of cash flows for the six months ended
June 30, 2022 and 2021:

                                                For the Six Months Ended June 30,
(in thousands)                                     2022                   2021

Net cash used by operating activities $ (60,197 ) $

  (21,191 )
Net cash used by investing activities        $         (3,161 )     $         (2,971 )
Net cash generated by financing activities   $         92,520       $       

17,983

Net increase (decrease) in cash flows $ 29,162 $


  (6,179 )



Operating Activities
Cash used in operating activities for the six months ended June 30, 2022 and
2021 was $60.2 million and $21.2 million, respectively. The increase in
operating cash outflows in 2022 was partly due to higher operating losses in the
current year. Additionally, we used a portion of the proceeds from the Business
Combination described below in Financing Activities to make cash payments
related to various transaction and other costs that became due as a result of
the Business Combination.


                                       33

--------------------------------------------------------------------------------

Investing Activities
Cash used in investing activities for the six months ended June 30, 2022 and
2021 was $3.2 million and $3.0 million, respectively. The increase was
attributable to capitalized software development costs during the period.

Financing Activities
Cash provided by financing activities for the six months ended June 30, 2022 and
2021 was $92.5 million and $18.0 million, respectively.

In 2022, we received proceeds from the Business Combination of approximately
$97.5 million, net of transaction costs. A portion of those proceeds were used
to settle debt obligations of $3.8 million and to pay various transaction and
other expenses included in Operating Activities above. Additionally, we made
payments of approximately $1.4 million related to deferred underwriting fees
associated with the ENNV IPO in 2021 that were assumed as a result of the
Business Combination. Refer to Note 3 of the condensed consolidated financial
statements included elsewhere in this Report for additional information on the
Business Combination.

In 2021, we received proceeds of $11.0 million from the issuance of term loans and $7.6 million from the issuance of convertible notes and warrants to a related party that was partially offset by the repayment of outstanding indebtedness of $0.6 million.



Contractual Obligations
Our contractual obligations consist primarily of debt liabilities and operating
leases which impact our short-term and long-term liquidity and capital needs.
The table below is presented as of June 30, 2022 and reflects interest rates as
of that date.

                                                             Payments Due By Period
                                                                                                More than 5
(in thousands)                        Total         2022        2023-2024       2025-2026          years

Contractual obligations
Operating leases                     $  3,793     $    941     $     1,982     $       870     $           -
Debt                                   30,549       11,233          19,109             207                 -
Interest on debt                        1,592        1,038             548               6                 -
Purchase commitments                   10,125        5,625           2,250           2,250                 -

Total contractual obligations $ 46,059 $ 18,837 $ 23,889

    $     3,333     $           -



Off-Balance Sheet Arrangements
As of June 30, 2022 and December 31, 2021, we did not have any off-balance sheet
arrangements, as defined in Regulation S-K, Item 303(a)(4)(ii).

Critical Accounting Policies and Estimates
The preparation of consolidated financial statements, in conformity with GAAP,
requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, and disclosure of contingent assets and
liabilities at the date of the financial statements, and the reported amounts of
revenues and expenses during the reporting period. Our most significant
estimates and judgements involve valuation of our equity, including assumptions
made in the fair value of stock-based compensation. Such policies are summarized
in the Management's Discussion and Analysis of Financial Condition and Results
of Operations section in our Current Report on Form 8-K/A filed with the SEC on
March 30, 2022. Although we regularly assess these estimates, actual results
could differ materially from these estimates. Changes in estimates are recorded
in the period in which they become known. We base our estimates on historical
experience and various other assumptions that we believe to be reasonable under
the circumstances. Actual results may differ from management's estimates if
these results differ from historical experience or other assumptions prove not
to be substantially accurate, even if such assumptions are reasonable when made.

© Edgar Online, source Glimpses